Comerica Bank Has $11.41 Million Stake in CME Group Inc. (CME)
Comerica Bank lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 0.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 83,846 shares of the financial services provider’s stock after purchasing an additional 413 shares during the period. Comerica Bank’s holdings in CME Group were worth $11,412,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the company. DekaBank Deutsche Girozentrale boosted its holdings in shares of CME Group by 0.4% during the third quarter. DekaBank Deutsche Girozentrale now owns 253,076 shares of the financial services provider’s stock worth $32,111,000 after purchasing an additional 1,084 shares during the period. Teacher Retirement System of Texas boosted its holdings in shares of CME Group by 31.0% during the third quarter. Teacher Retirement System of Texas now owns 4,626 shares of the financial services provider’s stock worth $628,000 after purchasing an additional 1,095 shares during the period. Rhumbline Advisers boosted its holdings in shares of CME Group by 2.3% during the third quarter. Rhumbline Advisers now owns 661,523 shares of the financial services provider’s stock worth $89,755,000 after purchasing an additional 14,879 shares during the period. Advisor Group Inc. boosted its holdings in shares of CME Group by 6.6% during the third quarter. Advisor Group Inc. now owns 23,178 shares of the financial services provider’s stock worth $3,143,000 after purchasing an additional 1,429 shares during the period. Finally, First National Trust Co. boosted its holdings in shares of CME Group by 21.8% during the third quarter. First National Trust Co. now owns 16,699 shares of the financial services provider’s stock worth $2,266,000 after purchasing an additional 2,990 shares during the period. Institutional investors own 82.63% of the company’s stock.
A number of equities analysts recently issued reports on the stock. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, September 13th. UBS AG reaffirmed a “buy” rating and set a $135.00 target price (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Royal Bank Of Canada set a $135.00 target price on shares of CME Group and gave the company a “buy” rating in a research note on Tuesday, August 1st. Citigroup Inc. raised their target price on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 target price on shares of CME Group in a research note on Friday, August 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $141.75.
Shares of CME Group Inc. (NASDAQ CME) traded down $0.44 during mid-day trading on Friday, reaching $139.65. 102,831 shares of the company traded hands, compared to its average volume of 1,359,468. CME Group Inc. has a 52 week low of $111.19 and a 52 week high of $141.44. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $47,364.19, a PE ratio of 29.22, a P/E/G ratio of 2.87 and a beta of 0.71.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter last year, the company posted $1.05 earnings per share. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. analysts predict that CME Group Inc. will post 4.78 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 1.89%. The ex-dividend date is Thursday, December 7th. CME Group’s dividend payout ratio is currently 59.86%.
In other news, Director Daniel R. Glickman sold 850 shares of CME Group stock in a transaction on Monday, August 28th. The shares were sold at an average price of $126.65, for a total transaction of $107,652.50. Following the transaction, the director now owns 13,799 shares in the company, valued at approximately $1,747,643.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 714 shares of CME Group stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $129.00, for a total transaction of $92,106.00. Following the transaction, the insider now owns 28,844 shares in the company, valued at approximately $3,720,876. The disclosure for this sale can be found here. Insiders sold 11,339 shares of company stock worth $1,548,086 in the last 90 days. 0.57% of the stock is currently owned by corporate insiders.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.